Triple‐negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer characterized by the absence of three essential receptors: estrogen, progesterone, and human epidermal growth factor receptor 2 (HER2) (Bianchini et al. 2022; Wang, Hao, et al. 2024). The gene discussed is ERBB2; the disease is breast cancer.